ArticleCancer cell2010

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K.

Jessie Villanueva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.